Skip to main content

Identification of Individuals with Post-Bariatric Hypoglycemia in U.S. Claims Data: Insights and Opportunities

Lead Author: Shannon Grabich (Presenter)

Published: ObesityWeek 2026

Date: November 16, 2026

Read more (opens new window)

Avexitide for Post-Bariatric Hypoglycemia: Results from the Pivotal Phase 3 LUCIDITY Trial

Lead Author: Marilyn Tan, MD, FACE, FACP (Presenter)

Published: ObesityWeek 2026

Date: November 15, 2026

Read more (opens new window)

Reflections on the Amylyx ORION Trial: Informing Future PSP Research

Lead Author: Jamie Timmons, MD

Published: Neuro2026: The PSP and CBD International Research Symposium

Date: November 5, 2026

Read more (opens new window)

LUMINA: AMX0114 ALS Study Update

Lead Author: Lauren Kett, MD, PhD and Sabrina Paganoni, MD, PhD (Co-Presenters)

Published: 2026 Annual NEALS Meeting

Date: October 28, 2026

Read more (opens new window)

Advancing AMX0114 for ALS: Updates from the LUMINA Phase 1 Study

Lead Author: Lauren Kett, MD, PhD (Presenter)

Published: European Network to Cure ALS (ENCALS) 2026 Meeting

Date: June 24, 2026

Read more (opens new window)

Participant-Informed Design Considerations in Phase 3 LUCIDITY Trial of Avexitide for Post-Bariatric Hypoglycemia

Lead Author: Marilyn Tan, MD, FACE (Presenter)

Published: Endocrine Society’s Annual Meeting (ENDO 2026)

Date: June 15, 2026

Read more (opens new window)

Characterizing the Burden of Post-Bariatric Hypoglycemia in the United States

Lead Author: Colleen Craig, MD (Presenter)

Published: Endocrine Society’s Annual Meeting (ENDO 2026)

Date: June 14, 2026

Read more (opens new window)

AMX0035 in Wolfram Syndrome: Program Progress and Emerging Insights

Lead Author: Jamie Timmons, MD (Presenter)

Published: Wolfram Syndrome UK’s International Researcher’s Symposium

Date: June 4, 2026

Read more (opens new window)

Phase 2 trial of sodium phenylbutyrate and taurursodiol in Wolfram syndrome

Lead Author: Fumihiko Urano, MD, PhD

Published: The Journal of Clinical Investigation

Date: May 15, 2026

Read more (opens new window)

Initial Safety Findings from the Phase 1 LUMINA Trial of AMX0114 in Amyotrophic Lateral Sclerosis

Lead Author: Lauren Kett, MD, PhD (Presenter)

Published: Muscular Dystrophy Association (MDA) Clinical & Scientific Conference 2026

Date: March 11, 2026

Read more (opens new window)